Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hyperthermia is a condition of abnormally high core body temperature due to failed thermoregulation, typically from exogenous heat exposure and/or excessive endogenous heat production, distinct from fever in which the hypothalamic set point is elevated; it spans heat-related illnesses such as heat exhaustion and heatstroke and requires rapid cooling and supportive care in severe cases
null (for targeting “hyperthermia” as a molecule/receptor). For malignant hyperthermia specifically, pathogenic gain-of-function variants in RYR1 lead to excessive Ca2+ release in skeletal muscle when exposed to triggering anesthetics, causing a hypermetabolic crisis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hyperthermia.